Cytostatic drugs and metabolites in municipal and hospital wastewaters in Spain: Filtration, occurrence, and environmental risk

Science of the Total Environment

Volumn 497-498, Issue , 2014, Pages 68-77

  Negreira, Noelia ^a   de Alda, Miren López ^a   Barceló, Damià ^a,b  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

Author keywords

Cytostatics; Filtration; Liquid chromatography mass spectrometry; Occurrence; Risk assessment; Wastewater

Indexed keywords

BIOMOLECULES; DRUG PRODUCTS; FILTRATION; HOSPITALS; INTERNATIONAL COOPERATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PHASE SEPARATION; RISK ASSESSMENT; WASTEWATER; WATER FILTRATION;

ANTINEOPLASTIC AGENTS; CYTOSTATICS; HOSPITAL WASTEWATER; INTERNATIONAL AGENCY FOR RESEARCH ON CANCERS; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; OCCURRENCE; ON-LINE SOLID PHASE EXTRACTION; WASTEWATER TREATMENT PLANTS;

WASTEWATER TREATMENT;

CAPECITABINE; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DOXORUBICIN; DRUG METABOLITE; ENDOXIFEN; HYDROXYPACLITAXEL; HYDROXYTAMOXIFEN; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; TAMOXIFEN; UNCLASSIFIED DRUG; WASTE WATER; WATER POLLUTANT;

CARCINOGEN; DRUG; ENVIRONMENTAL RISK; FILTRATION; HOSPITAL SECTOR; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; MUNICIPAL SOLID WASTE; RISK ASSESSMENT; WASTEWATER;

ARTICLE; CONCENTRATION (PARAMETERS); FILTRATION; HOSPITAL WASTE; LIQUID CHROMATOGRAPHY; POLLUTION MONITORING; RISK ASSESSMENT; SOLID PHASE EXTRACTION; SPAIN; TANDEM MASS SPECTROMETRY; WASTE COMPONENT REMOVAL; WASTE WATER; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; WATER CYCLE; WATER SAMPLING; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; SEWAGE; WATER POLLUTANT;

SPAIN;

CHROMATOGRAPHY, LIQUID; CYTOSTATIC AGENTS; ENVIRONMENTAL MONITORING; SOLID PHASE EXTRACTION; SPAIN; TANDEM MASS SPECTROMETRY; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84905574596     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.07.101     Document Type: Article

References (58)

1. Andersen H.-R., Wollenberger L., Halling-Sørensen B., Kusk K.-O. Development of copepod nauplii to copepodites-a parameter for chronic toxicity including endocrine disruption. Environ Toxicol Chem 2001, 20:2821-2829.
2. Besse J.-P., Latour J.-F., Garric J. Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?. Environ Int 2012, 39:73-86.
3. Booker V., Halsall C., Llewellyn N., Johnson A., Williams R. Prioritising anticancer drugs for environmental monitoring and risk assessment purposes. Sci Total Environ 2014, 473-474:159-170.
4. Brezosek P., Elersek T., Filipic M. Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis. Water Res 2014, 52:168-177.
5. Buerge I.J., Buser H.-R., Poiger T., Mu¨ller M.D. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ Sci Technol 2006, 40:7242-7250.
6. Castiglioni S., Bagnati R., Calamari D., Fanelli R., Zuccato E. A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. J Chromatogr A 2005, 1092:206-215.
7. DellaGreca M., Iesce M.R., Isidori M., Nardelli A., Previtera L., Rubino M. Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms. Chemosphere 2007, 67:1933-1939.
8. European Commission (EC). Technical Guidance Document on Risk Assessment in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances; Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances; Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, 2003.
9. Ferk F., Misˇi´k M., Grummt T., Majer B., Fuerhacker M., Buchmann C., et al. Genotoxic effects of wastewater from an oncological ward. Mutat Res-Gen Tox En 2009, 672:69-75.
10. Ferrando-Climent L., Rodriguez-Mozaz S., Barcelo´ D. Development of a UPLC-MS/MS method for the determination of ten anticancer drugs in hospital and urban wastewaters, and its application for the screening of human metabolites assisted by information-dependent acquisition tool (IDA) in sewage samples. Anal Bioanal Chem 2013, 405:5937-5952.
11. Geric´ M., Gajski G., Garaj-Vrhovac V. γ-H2AX as a biomarker for DNA double-strand breaks in ecotoxicology. Ecotoxicol Environ Saf 2014, 105:13-21.
12. Ginebreda A., Munoz I., de Alda M.L., Brix R., Lopez-Doval J., Barcelo D. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ Int 2010, 36:153-162.
13. Giuliani F., Koller T., Wu¨rgler F.E., Widmer R.M. Detection of genotoxic activity in native hospital waste water by the umuC test. Mutat Res-Gen Tox En 1996, 368:49-57.
14. Go´mez-Canela C., Corte´s-Francisco N., Oliva X., Pujol C., Ventura F., Lacorte S., et al. Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis-liquid chromatography-high-resolution mass spectrometry. Environ Sci Pollut Res 2012, 19:3210-3218.
15. Go´mez-Canela C., Ventura F., Caixach J., Lacorte S. Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry. Anal Bioanal Chem 2014, 406:3801-3814.
16. Henschel K.P., Wenzel A., Diedrich M., Fliedner A. Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharmacol 1997, 25:220-225.
17. International Agency on the Research on Cancer I Agents Classified by the IARC Monographs 2012, [http://monographs.iarc.fr/ENG/Classification/ update 28 june 2012; Volumes 1-105].
18. Jager N.G.L., Rosing H., Linn S.C., Schellens J.H.M., Beijnen J.H. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen. Breast Cancer Res Treat 2012, 133:793-798.
19. Johnson A.C., Ju¨rgens M.D., Williams R.J., Ku¨mmerer K., Kortenkamp A., Sumpter J.P. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J Hydrol 2008, 348:167-175.
20. Jolibois B., Guerbet M., Vassal S. Detection of hospital wastewater genotoxicity with the SOS chromotest and Ames fluctuation test. Chemosphere 2003, 51:539-543.
21. Kiffmeyer T., Go¨tze H.-J., Jursch M., Lu¨ders U. Trace enrichment, chromatographic separation and biodegradation of cytostatic compounds in surface water. Fresenius J Anal Chem 1998, 361:185-191.
22. Kosjek T., Heath E. Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. TRAC-Trend Anal Chem 2011, 30:1065-1087.
23. Kosjek T., Perko S., Zˇigon D., Heath E. Fluorouracil in the environment: analysis, occurrence, degradation and transformation. J Chromatogr A 2013, 1290:62-72.
24. Kovalova L., McArdell C.S., Hollender J. Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry. J Chromatogr A 2009, 1216:1100-1108.
25. Ku¨mmerer K., Al-Ahmad A. Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water. Environ Sci Pollut Res 2010, 17:486-496.
26. Ku¨mmerer K., Steger-Hartmann T., Meyer M. Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res 1997, 31:2705-2710.
27. Ku¨mmerer K., Al-Ahmad A., Bertram B., Wießler M. Biodegradability of antineoplastic compounds in screening tests: influence of glucosidation and of stereochemistry. Chemosphere 2000, 40:767-773.
28. Lenz K., Koellensperger G., Hann S., Weissenbacher N., Mahnik S.N., Fuerhacker M. Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 2007, 69:1765-1774.
29. Liu X., Zhang J., Yin J., Duan H., Wu Y., Shao B. Analysis of hormone antagonists in clinical and municipal wastewater by isotopic dilution liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 2010, 396:2977-2985.
30. Lo´pez-Serna R., Petrovic´ M., Barcelo´ D. Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain). Sci Total Environ 2012, 440:280-289.
31. Lo´pez-Serna R., Jurado A., Va´zquez-Suñe´ E., Carrera J., Petrovic´ M., Barcelo´ D. Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain. Environ Pollut 2013, 174:305-315.
32. Mahnik S.N., Rizovski B., Fuerhacker M., Mader R.M. Determination of 5-fluorouracil in hospital effluents. Anal Bioanal Chem 2004, 380:31-35.
33. Mahnik S.N., Rizovski B., Fuerhacker M., Mader R.M. Development of an analytical method for the determination of anthracyclines in hospital effluents. Chemosphere 2006, 65:1419-1425.
34. Mahnik S.N., Lenz K., Weissenbacher N., Mader R.M., Fuerhacker M. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 2007, 66:30-37.
35. Martin J., Camacho-Munoz D., Santos J.L., Aparicio I., Alonso E. Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography-triple-quadrupole mass spectrometry. J Sep Sci 2011, 34:3166-3177.
36. Mater N., Geret F., Castillo L., Faucet-Marquis V., Albasi C., Pfohl-Leszkowicz A. In vitro tests aiding ecological risk assessment of ciprofloxacin, tamoxifen and cyclophosphamide in range of concentrations released in hospital wastewater and surface water. Environ Int 2014, 63:191-200.
37. Mullot J.U., Karolak S., Fontova A., Huart B., Levi Y. Development and validation of a sensitive and selective method using GC/MS-MS for quantification of 5-fluorouracil in hospital wastewater. Anal Bioanal Chem 2009, 394:2203-2212.
38. Negreira N., Lopez de Alda M., Barcelo D. On-line solid phase extraction-liquid chromatography-tandem mass spectrometry for the determination of 17 cytostatics and metabolites in waste, surface and ground water samples. J Chromatogr A 2013, 1280:64-74.
39. Negreira N., Mastroianni N., Lo´pez De Alda M., Barcelo´ D. Multianalyte determination of 24 cytostatics and metabolites by liquid chromatography-electrospray-tandem mass spectrometry and study of their stability and optimum storage conditions in aqueous solution. Talanta 2013, 116:290-299.
40. Negreira N., Lo´pez de Alda M., Barcelo´ D. Study of the stability of 26 cytostatic drugs and metabolites in wastewater under different conditions. Sci Total Environ 2014, 482-483:389-398.
41. Nussbaumer S., Bonnabry P., Veuthey J.-L., Fleury-Souverain S. Analysis of anticancer drugs: a review. Talanta 2011, 85:2265-2289.
42. Parrella A., Lavorgna M., Criscuolo E., Russo C., Fiumano V., Isidori M. Acute and chronic toxicity of six anticancer drugs on rotifers and crustaceans. Chemosphere 2014, 10.1016/j.chemosphere.2014.01.013.
43. Pomati F., Castiglioni S., Zuccato E., Fanelli R., Vigetti D., Rossetti C., et al. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ Sci Technol 2006, 40:2442-2447.
44. Regueiro J., Matamoros V., Thibaut R., Porte C., Bayona J.M. Use of effect-directed analysis for the identification of organic toxicants in surface flow constructed wetland sediments. Chemosphere 2013, 91:1165-1175.
45. Ribes J., Clries R., Buxo´ M., Ameijide A., Valls J., Gispert R. Predictions of cancer incidence and mortality in Catalonia to 2015 by means of Bayesian models. Proyeccio´n de la incidencia y la mortalidad del ca´ncer en Cataluña hasta el año 2015 mediante un modelo bayesiano 2008, 131:32-41.
46. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 2006, 356:143-153.
47. Roig B., Marquenet B., Delpla I., Bessonneau V., Sellier A., Leder C., et al. Monitoring of methotrexate chlorination in water. Water Res 2014, 57:67-75.
48. Santos L.H.M.L.M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barcelo´ D., et al. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci Total Environ 2013, 461-462:302-316.
49. Seira J., Claparols C., Joannis-Cassan C., Albasi C., Montre´jaud-Vignoles M., Sablayrolles C. Optimization of pressurized liquid extraction using a multivariate chemometric approach for the determination of anticancer drugs in sludge by ultra high performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 2013, 1283:27-38.
50. Steger-Hartmann T., Ku¨mmerer K., Schecker J. Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by twostep solid-phase extraction and gas chromatography-mass spectrometry. J Chromatogr A 1996, 726:179-184.
51. Steger-Hartmann T., Ku¨mmerer K., Hartmann A. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol Environ Saf 1997, 36:174-179.
52. Toolaram A.P., Ku¨mmerer K., Schneider M. Environmental risk assessment of anti-cancer drugs and their transformation products: a focus on their genotoxicity characterization-state of knowledge and short comings. Mutat Res Rev Mutat 2014, 760:18-35.
53. van Nuijs A.L., Tarcomnicu I., Covaci A. Application of hydrophilic interaction chromatography for the analysis of polar contaminants in food and environmental samples. J Chromatogr A 2011, 1218:5964-5974.
54. Williams T.D., Caunter J.E., Lillicrap A.D., Hutchinson T.H., Gillings E.G., Duffell S. Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas). Environ Toxicol Chem 2007, 26:695-707.
55. Yin J., Shao B., Zhang J., Li K. A preliminary study on the occurrence of cytostatic drugs in hospital effluents in Beijing, China. Bull Environ Contam Toxicol 2010, 84:39-45.
56. Zhang W., Dutschman G.E., Li X., Cheng Y.-C. Quantitation of paclitaxel and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B 2011, 879:2018-2022.
57. Zhang J., Chang V.W.C., Giannis A., Wang J.-Y. Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ 2013, 445-446:281-298.
58. Zounkova´ R., Odra´sˇka P., Dolezˇalova´ L., Hilscherova´ K., Marsˇa´lek B., Bla´ha L. Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals. Environ Toxicol Chem 2007, 26:2208-2214.